LMNL - Liminal BioSciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Liminal BioSciences's activity chart (see below) currently has 3 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 205.5 days.

Most recent stock forecast was given by from on 24-Jun-2021. First documented stock forecast 21-Dec-2020.

Best performing analysts who are covering LMNL - Liminal BioSciences:

Yasmeen Rahimi Edwin Zhang

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-Feb-2021

$11

5 years 2 months 21 days ago
(24-Jun-2021)

1/1 (100%)

$-51.9 (-82.51%)

288

Buy Since 21-Dec-2020

$45

$36.5 (429.41%)

$22

5 years 3 months 12 days ago
(02-Jun-2021)

2/2 (100%)

$1.6 (3.69%)

123

Show more analysts

Please expand the browser size to see the chart

What is LMNL (Liminal BioSciences) average time for price targets to be met?

On average it took 206 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on LMNL (Liminal BioSciences)?

Which analyst has the current lower performing score on LMNL (Liminal BioSciences) with a proven track record?

EDWIN ZHANG

Which analyst has the most public recommendations on LMNL (Liminal BioSciences)?

has 0 price targets and 0 ratings on LMNL

Which analyst is the currently most bullish on LMNL (Liminal BioSciences)?

Yasmeen Rahimi with the highest potential upside of $36.5

Which analyst is the currently most reserved on LMNL (Liminal BioSciences)?

Edwin Zhang with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?